Literature DB >> 26582957

Evolutionarily Successful Asian 1 Dengue Virus 2 Lineages Contain One Substitution in Envelope That Increases Sensitivity to Polyclonal Antibody Neutralization.

Chunling Wang1, Leah C Katzelnick2, Magelda Montoya1, Kien Duong Thi Hue3, Cameron P Simmons4, Eva Harris1.   

Abstract

The 4 dengue virus serotypes (DENV-1-4) cause the most prevalent mosquito-borne viral disease of humans worldwide. DENV-2 Asian 1 (A1) genotype viruses replaced the Asian-American (AA) genotype in Vietnam and Cambodia, after which A1 viruses containing Q or M at envelope (E) residue 160 became more prevalent than those with residue 160K in both countries (2008-2011). We investigated whether these substitutions conferred a fitness advantage by measuring neutralizing antibody titer against reporter virus particles (RVPs) representing AA, A1-160K, A1-160Q, and A1-160M, using patient sera from Vietnam and a well-characterized Nicaraguan cohort. Surprisingly, we found that A1-160Q and A1-160M RVPs were better neutralized by heterologous antisera than A1-160K. Despite this, Vietnamese patients infected with A1-160Q or A1-160M viruses had higher viremia levels than those infected with A1-160K. We thus found that independent lineages in Vietnam and Cambodia acquired a substitution in E that significantly increased polyclonal neutralization but nonetheless were successful in disseminating and infecting human hosts.
© The Author 2015. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Cambodia; Vietnam; dengue virus; envelope protein; evolution; fitness; genotype; lineage; neutralizing antibodies

Mesh:

Substances:

Year:  2015        PMID: 26582957      PMCID: PMC4760423          DOI: 10.1093/infdis/jiv536

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  47 in total

1.  Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation.

Authors:  Camilo Ansarah-Sobrinho; Steevenson Nelson; Christiane A Jost; Stephen S Whitehead; Theodore C Pierson
Journal:  Virology       Date:  2008-09-17       Impact factor: 3.616

2.  Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.

Authors:  Soila Sukupolvi-Petty; S Kyle Austin; Michael Engle; James D Brien; Kimberly A Dowd; Katherine L Williams; Syd Johnson; Rebeca Rico-Hesse; Eva Harris; Theodore C Pierson; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

3.  The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.

Authors:  Martina Beltramello; Katherine L Williams; Cameron P Simmons; Annalisa Macagno; Luca Simonelli; Nguyen Than Ha Quyen; Soila Sukupolvi-Petty; Erika Navarro-Sanchez; Paul R Young; Aravinda M de Silva; Félix A Rey; Luca Varani; Stephen S Whitehead; Michael S Diamond; Eva Harris; Antonio Lanzavecchia; Federica Sallusto
Journal:  Cell Host Microbe       Date:  2010-09-16       Impact factor: 21.023

4.  Genotype-specific neutralization and protection by antibodies against dengue virus type 3.

Authors:  James D Brien; S Kyle Austin; Soila Sukupolvi-Petty; Katie M O'Brien; Syd Johnson; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

5.  The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.

Authors:  Bimmi Shrestha; James D Brien; Soila Sukupolvi-Petty; S Kyle Austin; Melissa A Edeling; Taekyung Kim; Katie M O'Brien; Christopher A Nelson; Syd Johnson; Daved H Fremont; Michael S Diamond
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

6.  Emergence of the Asian 1 genotype of dengue virus serotype 2 in viet nam: in vivo fitness advantage and lineage replacement in South-East Asia.

Authors:  Thi Ty Hang Vu; Edward C Holmes; Veasna Duong; Thien Quy Nguyen; Tinh Hien Tran; Michael Quail; Carol Churcher; Julian Parkhill; Jane Cardosa; Jeremy Farrar; Bridget Wills; Niall J Lennon; Bruce W Birren; Philippe Buchy; Matthew R Henn; Cameron P Simmons
Journal:  PLoS Negl Trop Dis       Date:  2010-07-20

7.  Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua.

Authors:  Angel Balmaseda; Katherine Standish; Juan Carlos Mercado; Juan Carlos Matute; Yolanda Tellez; Saira Saborío; Samantha N Hammond; Andrea Nuñez; William Avilés; Matthew R Henn; Edward C Holmes; Aubree Gordon; Josefina Coloma; Guillermina Kuan; Eva Harris
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

8.  Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance.

Authors:  Stephen J Thomas; Ananda Nisalak; Kathryn B Anderson; Daniel H Libraty; Siripen Kalayanarooj; David W Vaughn; Robert Putnak; Robert V Gibbons; Richard Jarman; Timothy P Endy
Journal:  Am J Trop Med Hyg       Date:  2009-11       Impact factor: 2.345

9.  Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes.

Authors:  Kimberly Mattia; Bridget A Puffer; Katherine L Williams; Ritela Gonzalez; Meredith Murray; Emily Sluzas; Dan Pagano; Sandya Ajith; Megan Bower; Eli Berdougo; Eva Harris; Benjamin J Doranz
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

10.  A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins.

Authors:  Guntur Fibriansah; Joanne L Tan; Scott A Smith; Ruklanthi de Alwis; Thiam-Seng Ng; Victor A Kostyuchenko; Ramesh S Jadi; Petra Kukkaro; Aravinda M de Silva; James E Crowe; Shee-Mei Lok
Journal:  Nat Commun       Date:  2015-02-20       Impact factor: 14.919

View more
  5 in total

1.  Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype.

Authors:  Kimberly A Dowd; Christina R DeMaso; Rebecca S Pelc; Scott D Speer; Alexander R Y Smith; Leslie Goo; Derek J Platt; John R Mascola; Barney S Graham; Mark J Mulligan; Michael S Diamond; Julie E Ledgerwood; Theodore C Pierson
Journal:  Cell Rep       Date:  2016-07-29       Impact factor: 9.423

Review 2.  Dengue: knowledge gaps, unmet needs, and research priorities.

Authors:  Leah C Katzelnick; Josefina Coloma; Eva Harris
Journal:  Lancet Infect Dis       Date:  2017-02-07       Impact factor: 25.071

3.  Rise and fall of vector infectivity during sequential strain displacements by mosquito-borne dengue virus.

Authors:  C C Andrade; K I Young; W L Johnson; M E Villa; C A Buraczyk; W B Messer; K A Hanley
Journal:  J Evol Biol       Date:  2016-08-08       Impact factor: 2.411

4.  Beneath the surface: Amino acid variation underlying two decades of dengue virus antigenic dynamics in Bangkok, Thailand.

Authors:  Angkana T Huang; Henrik Salje; Ana Coello Escoto; Nayeem Chowdhury; Christian Chávez; Bernardo Garcia-Carreras; Wiriya Rutvisuttinunt; Irina Maljkovic Berry; Gregory D Gromowski; Lin Wang; Chonticha Klungthong; Butsaya Thaisomboonsuk; Ananda Nisalak; Luke M Trimmer-Smith; Isabel Rodriguez-Barraquer; Damon W Ellison; Anthony R Jones; Stefan Fernandez; Stephen J Thomas; Derek J Smith; Richard Jarman; Stephen S Whitehead; Derek A T Cummings; Leah C Katzelnick
Journal:  PLoS Pathog       Date:  2022-05-02       Impact factor: 7.464

5.  A novel mechanism of antibody-mediated enhancement of flavivirus infection.

Authors:  Denise Haslwanter; Dieter Blaas; Franz X Heinz; Karin Stiasny
Journal:  PLoS Pathog       Date:  2017-09-15       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.